🔎 Trials Near Me

Home › COPD › Florida

Pag-aaral pangklinika para sa COPD sa Florida

31 pag-aaral para sa COPD ang naghahanap ng mga kalahok sa mga site sa Florida.

Mga Lungsod sa Florida

Opisyal na teksto ng pag-aaral (English)

A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)

  • GSK Investigational Site, Doral
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07780669

A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)

  • GSK Investigational Site, Cape Coral
  • GSK Investigational Site, Greenacres City
  • GSK Investigational Site, Miami
  • at 1 pa
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07780656

Ensifentrine (MK-5884) Study for the Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in Adults With a History of Moderate or Severe Exacerbations While Receiving Standard of Care (SOC) (MK-5884-031/RPL554/ENHANCE-3)

  • Family First Medical Research Center ( Site 4458), Hialeah Gardens
  • Advanced Pulmonary Research Institute ( Site 4427), Loxahatchee Groves
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07874815

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

  • Millennium Medical Research - Miami, Miami
  • Deluxe Health Center, Miami Lakes
  • Florida Institute For Clinical Research, LLC, Orlando
Nagre-recruitPhase 2
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07759245

Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD

  • Mayo Clinic Jacksonville, Jacksonville
Nagre-recruit
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07051707

Rademikibart IV for Acute Asthma and COPD Exacerbation

  • Pharmax Research of South Florida, Inc., Miami
Nagre-recruitPhase 2
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07705737

A Study to Investigate the Efficacy and Safety of Zelicapavir Compared With Placebo in Adults With RSV Who Are at High Risk for Severe Disease

  • C&A Clinical Trials Corp, Cape Coral
  • Continental Clinical Research, LLC, Miami
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT07908381

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

  • International Clinical Research, Altamonte Springs
  • Synergy Healthcare, LLC, Bradenton
  • K2 Medical Research Winter Garden LLC, Clermont
  • at 4 pa
Nagre-recruitPhase 2
Edad 40 hanggang 85 · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT07684820

A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)

  • GC2501 Study Site 103, Gainesville
  • GC2501 Study Site 105, Miami
Nagre-recruitPhase 3
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT07555483

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

  • Research Site, Brandon
  • Research Site, Cape Coral
  • Research Site, Clearwater
  • at 17 pa
Nagre-recruitPhase 2
Edad 40 pataas · Lahat ng kasarian · Na-update Okt 23, 2026 · NCT07082738

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

  • Meris Clinical Research- Site Number : 8400153, Brandon
  • Hillcrest Medical Research- Site Number : 8400082, DeLand
  • Finlay Medical Research - Greenacres- Site Number : 8400107, Greenacres City
  • at 18 pa
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Okt 23, 2026 · NCT07190222

A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)

  • WB Contracted Clinical Research Site, Jacksonville
  • WB Contracted Clinical Research Site, Miami Lakes
Nagre-recruitPhase 2
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Okt 23, 2026 · NCT07646587

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

  • Finlay Medical Research, Greenacres City
  • Clinical Research Specialists LLC, Kissimmee
  • Advanced Pulmonary Research Institute, Loxahatchee Groves
  • at 9 pa
Nagre-recruitPhase 2/3
Edad 35 hanggang 80 · Lahat ng kasarian · Na-update Okt 22, 2026 · NCT07363694

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

  • University of Miami Dermatology Clinical Trials Unit- Site Number : 8400015, Miami
  • Finlay Medical Research- Site Number : 8400010, Miami
Nagre-recruitPhase 4
Edad 40 hanggang 85 · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT07053423

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

  • Mayo Clinic, Jascksonville
  • Orlando Health, Orlando
Nagre-recruit
Edad 40 hanggang 84 · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT06891755

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

  • Helix Biomedics- Site Number : 8400065, Boynton Beach
  • Beautiful Minds Clinical Research Center- Site Number : 8400017, Cutler Bay
  • Eastern Medical Group Research- Site Number : 8400020, Fort Myers
  • at 11 pa
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT07190209

Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cells for Pulmonary Diseases

  • Prodromos Stem Cell Institute, Naples
Nagre-recruitPhase 1
Lahat ng edad · Lahat ng kasarian · Na-update Okt 16, 2026 · NCT05147688

STRIVE Post-Market Registry Study

  • University of Miami, Coral Gables
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 16, 2026 · NCT04302272

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

  • Research Site, Bay Pines
  • Research Site, Boynton Beach
  • Research Site, Jacksonville
  • at 4 pa
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Okt 9, 2026 · NCT06878261

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

  • GSK Investigational Site, Brooksville
  • GSK Investigational Site, Doral
  • GSK Investigational Site, Fort Lauderdale
  • at 16 pa
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06961214

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation

  • GSK Investigational Site, Bradenton
  • GSK Investigational Site, Brandon
  • GSK Investigational Site, Hialeah
  • at 12 pa
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06959095

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

  • Research Site, Boynton Beach
  • Research Site, Bradenton
  • Research Site, Cape Coral
  • at 25 pa
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06283966

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

  • Orlando Health, Orlando
Nagre-recruit
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06035120

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

  • University of Florida, Jacksonville
Nagre-recruitPhase 2
Edad 40 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07059091

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

  • Research Site, Clearwater
  • Research Site, Cutler Bay
  • Research Site, Cutler Bay
  • at 9 pa
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06883305

Alpha-1 Research Registry

  • Alpha-1 Foundation, Coral Gables
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT04157049

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

  • GSK Investigational Site, Brandon
  • GSK Investigational Site, Crystal River
  • GSK Investigational Site, Doral
  • at 8 pa
Nagre-recruitPhase 3
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT07177339

Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD

  • University of Miami, Miami
Nagre-recruit
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Hun 22, 2026 · NCT06578156

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

  • Hillcrest Medical Research, DeLand
  • Universal Axon Clinical Research, Doral
  • I.H.S Health, LLC, Kissimmee
  • at 3 pa
Nagre-recruitObservasyonal na pag-aaral
Edad 50 pataas · Lahat ng kasarian · Na-update Ago 5, 2025 · NCT06122077

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

  • University of Florida, Jacksonville, Jacksonville
  • Alloy Clinical Research, Kissimmee
  • Reliable Research, Inc., Miami
  • at 2 pa
Nagre-recruit
Edad 30 pataas · Lahat ng kasarian · Na-update Peb 6, 2025 · NCT05204888

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.